co-diagnostics
-
Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28
In addition to hosting a booth to promote its existing diagnostics products at the conference, the Company will…
-
Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion
Co-Diagnostics, Inc. announced that following its recent transformative growth, the Company is rebranding its image to better reflect…
-
Co-Diagnostics, Inc. CEO to Participate in Panel Discussion with Scott Gottlieb, M.D., at H.C. Wainwright 2021 Annual Global Investor Conference
On September 13th, Co-Diagnostics, Inc. announced that Company CEO Dwight Egan will participate in a panel discussion hosted…
-
Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy
Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste,…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
